New Prostate Cancer Biomarkers Can Improve Precision Therapy
Improvements are on the horizon in the treatment of prostate cancer that could improve future therapy.
Findings show small increased risk with white wine, decreased risk with red wine
High PSA levels and larger number of positive biopsy cores are associated with positive surgical margins and extracapsular extension/seminal vesicle invasion after radical prostatectomy.
The new statement emphasizes shared decision-making on screening for men aged 55 to 69 years who are at average risk for prostate cancer.